Alzheimer's disease with normal CSF biomarkers (original) (raw)

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years

Michael Jonsson

Journal of Alzheimer's disease : JAD, 2007

View PDFchevron_right

Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease

Elisabet Londos

PLoS ONE, 2009

View PDFchevron_right

CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment

Flavio Mercati

Journal of the …, 2006

View PDFchevron_right

Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice

Philip Scheltens

PLoS ONE, 2014

View PDFchevron_right

Alzheimer CSF biomarkers in routine clinical setting

Fernand BOUTROS-TONI

Acta Neurologica Scandinavica, 2011

View PDFchevron_right

CSF biomarkers for the differential diagnosis of Alzheimer's disease. A large-scale international multicenter study

Julius Popp, Jose Molinuevo

Alzheimer's & dementia : the journal of the Alzheimer's Association, 2015

View PDFchevron_right

Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting

Audrey Gabelle, Claire Paquet, Katell Peoc'H

Alzheimer's & Dementia, 2013

View PDFchevron_right

BRAIN_CSF biomarker profile in cognitively normal subjects.pdf

Harald Hampel

View PDFchevron_right

Could Clinical Profile Influence CSF Biomarkers in Early-onset Alzheimer Disease?

Olivier Felician

Alzheimer Disease & Associated Disorders, 2010

View PDFchevron_right

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

Anders Wallin

Neurobiology of Aging, 2009

View PDFchevron_right

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

Elisabet Londos

The Lancet Neurology, 2006

View PDFchevron_right

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Sebastiaan Engelborghs

Acta Neurologica Belgica, 2017

View PDFchevron_right

Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers

Robert Veerhuis

Neurobiology of Aging, 2012

View PDFchevron_right

CSF biomarkers for Alzheimer disease — approaching consensus

Leslie Shaw

Nature Reviews Neurology, 2017

View PDFchevron_right

Age and diagnostic performance of Alzheimer disease CSF biomarkers

Lennart Minthon, Lucilla Parnetti, Michael Jonsson, Harald Hampel, M. Tsolaki

Neurology, 2012

View PDFchevron_right

Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria

Lilisbeth Perestelo-pérez, Antonio Sarría

Frontiers in Aging Neuroscience, 2014

View PDFchevron_right

Validation of Alzheimer’s disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer’s Disease Neuroimaging Initiative (E-ADNI)

Peter Johannsen

Experimental Gerontology, 2009

View PDFchevron_right

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

Elisabet Londos

International Journal of Geriatric Psychiatry, 2009

View PDFchevron_right

CSF biomarker variability in the Alzheimer's Association quality control program

Piero Parchi

Alzheimer's & Dementia, 2013

View PDFchevron_right

Lessons from multicenter studies on CSF biomarkers for Alzheimer's disease

Niklas Mattsson

Alzheimer's & Dementia, 2011

View PDFchevron_right

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Sebastiaan Engelborghs

Alzheimer's & Dementia, 2016

View PDFchevron_right

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

Niels Andreasen

JAMA, 2009

View PDFchevron_right

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). (Review)

Steven Martin

View PDFchevron_right

CSF-tau, CSF-A�1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer?s disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity

Ulrike Beisiegel

Journal of Neural Transmission, 2003

View PDFchevron_right